ADVISORY, Dec. 20, 2011 (GLOBE NEWSWIRE) -- What: Coronado Biosciences (CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer, will visit the NASDAQ MarketSite in New York City’s Times Square.
